Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: PCskibum who wrote (11190)	4/25/2012 2:47:06 PM
From: Mammon	1 Recommendation Read Replies (1) \| Respond to of 13111

I'm no expert on the FDA and its proceedings, but a quick google search came up with this document about Incyte's dealings with the FDA and how many iterations they went through before reaching a trial design consensus for an SPA with the FDA. The articles notes "Levy estimated the company spent about five months and went through three iterations before reaching consensus with the FDA on the SPA." And this was after a much longer period of time back and forth on the trial design. Let me say this again, in case anyone started drinking early today. The word ITERATIONS is mentioned in the context of interfacing with the FDA regarding an acceptable trial protocol. docs.google.com

To: PCskibum who wrote (11190)	4/25/2012 5:30:23 PM
From: NTTG	3 Recommendations Read Replies (1) \| Respond to of 13111

I dont....as an investor I am interested in how to scope company prospects..PVCT is an interesting case study. The transformation of thought on this board from 2009 to today is testament to that...not because of my posts, but from the underlying frustration that promises made have not been delivered on. I think if you took a survey of the PVCT longs they would generally agree that they thought the company would have been further along heading into 2012 than they are. Read the PR's, even PVCT has started to come to terms with the reality of their situation.